CLINICAL ROLE -
Critical Success Factors for Commercializing Specialty Drugs, Cell and Gene Therapies
Although payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.”
Trends in Oncology Pharmacy Will Drive the Market Beyond 2022
New drugs, virtual care, and a patient-focused approach are
key during this period of transformation.
Innovative Patient-First Approach Enhances Patient Journey, Mitigates Rising Costs for Rare Disease Drugs
A patient’s ability to pay for specialty medications will continue to be an issue because drug costs are prohibitive and add barriers to accessibility.
Addressing the High Cost of Gene Therapies for Rare Diseases: An SPBM Perspective
As some of the nation’s leading pharmaceutical and biotech giants ramp up product development and commercialization, what was once a futuristic concept has become a reality.
Managing Adverse Events in Cancer Care: Addressing Blood Cell Counts and Drug Management
A proactive approach can ensure that the patient is getting the right therapy at the right time and the right treatment plan with the least amount of waste.
2 Clarke Drive Cranbury, NJ 08512